NOF Tip for 20 May – Vertebral Fractures

Vertebral Compression Fractures are often not recognized as anything more than a seriously pulled muscle.  I personally made that mistake 30+ years ago.  Only when I was tested on our...

Treat to Target #6 – Treatment

Our goal is NO NEW FRACTURES.  Therefore, Treat to Target means a FRAX score of <20% for “major osteoporotic” and <3% for hip fracture.  Alternately, T-score of better than -1.5 if...

Treat to Target #5 – VFA

Treat to Target of NO NEW FRACTURES.  How do we find that target?  DXA >-2.5 is a start.  Fragility fractures increase new fracture risk.  FRAX adds many more risk factors to the...

Treat to Target #4 – TBS

Our goal is NO NEW FRACTURES.  Cancellous (spongy, like the ends of the drumstick) bone should be a strong latticework of struts called trabeculi.  Clinical Osteoporosis, an increased fracture risk,...

“Treat to Target” and “Use VFA” in 2017

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd...

NOF & ISCD at “Clinical Osteoporosis 2017”

The National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD) are meeting together later this week.  This will be my 10th attendance at each group.  They are...

Adding VFA to DXA

I have let the regular posts to the blog lapse for quite some time, while working on other issues. I have been reviewing my first-time Vertebral Fracture Assessment (VFA) patients.  My...